Found: 21
Select item for more details and to access through your institution.
Pharmacokinetics of Subcutaneous Itepekimab Injection With an Autoinjector Device and Prefilled Syringe in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 11, p. 1181, doi. 10.1002/cpdd.1466
- By:
- Publication type:
- Article
Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 675, doi. 10.1002/cpdd.1073
- By:
- Publication type:
- Article
Drug‐Drug Interactions of Tacrolimus or Cyclosporine With Glecaprevir and Pibrentasvir in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 779, doi. 10.1002/cpdd.671
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 3, p. 365, doi. 10.1007/s40257-022-00683-2
- By:
- Publication type:
- Article
Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 11, p. 2653, doi. 10.1007/s11095-023-03616-8
- By:
- Publication type:
- Article
Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.
- Published in:
- Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 7, p. 409, doi. 10.1002/bdd.2023
- By:
- Publication type:
- Article
Nonlinear pharmacokinetics of factor VIII and its phosphatidylinositol lipidic complex in hemophilia A mice.
- Published in:
- Biopharmaceutics & Drug Disposition, 2014, v. 35, n. 3, p. 154, doi. 10.1002/bdd.1880
- By:
- Publication type:
- Article
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2697, doi. 10.1007/s13555-023-01016-9
- By:
- Publication type:
- Article
PEGylation of a Factor VIII–Phosphatidylinositol Complex: Pharmacokinetics and Immunogenicity in Hemophilia A Mice.
- Published in:
- AAPS Journal, 2012, v. 14, n. 1, p. 35, doi. 10.1208/s12248-011-9309-2
- By:
- Publication type:
- Article
Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 2, p. 217, doi. 10.1007/s00228-018-2576-4
- By:
- Publication type:
- Article
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 422, doi. 10.1002/cpt.3150
- By:
- Publication type:
- Article
The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1318, doi. 10.1002/cpt.2366
- By:
- Publication type:
- Article
Pharmacokinetics and Tolerability of a Dual Variable Domain Immunoglobulin ABT-981 Against IL-1α and IL-1β in Healthy Subjects and Patients With Osteoarthritis of the Knee.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 12, p. 1582, doi. 10.1002/jcph.764
- By:
- Publication type:
- Article
A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 7, p. 1056, doi. 10.1002/art.40840
- By:
- Publication type:
- Article
Dupilumab: Mechanism of action, clinical, and translational science.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.13899
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.13874
- By:
- Publication type:
- Article
Characterizing complex and competing drug–drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 4, p. 593, doi. 10.1111/cts.13471
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first‐in‐human and first‐in‐patient trials.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 384, doi. 10.1111/cts.13157
- By:
- Publication type:
- Article
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 664, doi. 10.1111/cts.12928
- By:
- Publication type:
- Article
AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.
- Published in:
- ERJ Open Research, 2024, v. 10, n. 5, p. 1, doi. 10.1183/23120541.00718-2023
- By:
- Publication type:
- Article
Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered With Human Immunodeficiency Virus Antiretrovirals.
- Published in:
- 2020
- By:
- Publication type:
- journal article